BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22696009)

  • 1. Early results with the use of heparin-bonded stent graft to rescue failed angioplasty of chronic femoropopliteal occlusive lesions: TASC D lesions have a poor outcome.
    Kuhan G; Abisi S; Braithwaite BD; MacSweeney ST; Whitaker SC; Habib SB
    Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1023-8. PubMed ID: 22696009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
    Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
    J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
    Tran K; Ullery BW; Kret MR; Lee JT
    Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
    Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
    J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous angioplasty and stenting of the superficial femoral artery.
    Surowiec SM; Davies MG; Eberly SW; Rhodes JM; Illig KA; Shortell CK; Lee DE; Waldman DL; Green RM
    J Vasc Surg; 2005 Feb; 41(2):269-78. PubMed ID: 15768009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subintimal angioplasty of chronic total occlusion in iliac arteries: a safe and durable option.
    Chen BL; Holt HR; Day JD; Stout CL; Stokes GK; Panneton JM
    J Vasc Surg; 2011 Feb; 53(2):367-73. PubMed ID: 21030201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes.
    Robinson WP; Nguyen LL; Bafford R; Belkin M
    J Vasc Surg; 2011 Mar; 53(3):651-7. PubMed ID: 21129908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iliac artery stenting combined with open femoral endarterectomy is as effective as open surgical reconstruction for severe iliac and common femoral occlusive disease.
    Piazza M; Ricotta JJ; Bower TC; Kalra M; Duncan AA; Cha S; Gloviczki P
    J Vasc Surg; 2011 Aug; 54(2):402-11. PubMed ID: 21531527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective stenting in subintimal angioplasty: analysis of primary stent outcomes.
    Schmieder GC; Richardson AI; Scott EC; Stokes GK; Meier GH; Panneton JM
    J Vasc Surg; 2008 Nov; 48(5):1175-80; discussion 1180-1. PubMed ID: 18778911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial.
    Saxon RR; Chervu A; Jones PA; Bajwa TK; Gable DR; Soukas PA; Begg RJ; Adams JG; Ansel GM; Schneider DB; Eichler CM; Rush MJ
    J Vasc Interv Radiol; 2013 Feb; 24(2):165-73; quiz 174. PubMed ID: 23369553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease.
    Dosluoglu HH; Cherr GS; Lall P; Harris LM; Dryjski ML
    J Vasc Surg; 2008 Nov; 48(5):1166-74. PubMed ID: 18692357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of endovascular treatment of TASC-II C and D femoropopliteal lesions with the Viabahn endoprosthesis.
    Mohr PJ; Oyama JK; Luu JT; Stinis CT
    Cardiovasc Revasc Med; 2015 Dec; 16(8):465-8. PubMed ID: 26483319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-II.
    Ichihashi S; Higashiura W; Itoh H; Sakaguchi S; Nishimine K; Kichikawa K
    J Vasc Surg; 2011 Apr; 53(4):992-9. PubMed ID: 21215582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
    Laird JR; Yeo KK; Rocha-Singh K; Das T; Joye J; Dippel E; Reddy B; Botti C; Jaff MR
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):852-9. PubMed ID: 22422738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic outcome of endovascular therapy for TransAtlantic InterSociety Consensus type B femoropopliteal arterial occlusive lesions.
    Costanza MJ; Queral LA; Lilly MP; Finn WR
    J Vasc Surg; 2004 Feb; 39(2):343-50. PubMed ID: 14743134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease.
    Johnston PC; Vartanian SM; Runge SJ; Hiramoto JS; Eichler CM; Owens CD; Schneider DB; Conte MS
    J Vasc Surg; 2012 Oct; 56(4):998-1006, 1007.e1; discussion 1006-7. PubMed ID: 22633429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions.
    Boufi M; Dona B; Orsini B; Auquier P; Hartung O; Alimi YS
    J Vasc Surg; 2010 Nov; 52(5):1211-7. PubMed ID: 20692789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovascular interventions for TransAtlantic InterSociety Consensus II C and D femoropopliteal lesions.
    Yin MY; Jiang ME; Huang XT; Lu M; Lu XW; Huang Y; Li WM
    Chin Med J (Engl); 2013 Feb; 126(3):415-20. PubMed ID: 23422099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions.
    Gabrielli R; Rosati MS; Vitale S; Baciarello G; Siani A; Chiappa R; Caselli G; Irace L
    J Vasc Surg; 2012 Dec; 56(6):1598-605. PubMed ID: 23044257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.